Evidence map›Paper›PMID 16594628›Full record

ReviewHandbook of experimental pharmacology2006

Locked nucleic acid: high-affinity targeting of complementary RNA for RNomics.

S Kauppinen, B Vester, J Wengel

Open access · bronzeAbstract readReview
In one paragraph

Review in Handbook of experimental pharmacology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
19.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Expression ofMolecular therapy. Nucleic acids · 2023
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Journal of cytology & histology · 2015
    Article
  13. Review
  14. Article
  15. Article
  16. The non-coding road towards cardiac regeneration.Journal of cardiovascular translational research · 2013
    Review
  17. MicroRNAs as potential clinical biomarkers: emerging approaches for their detection.Biotechnic & histochemistry : official publication of the Biological Stain Commission · 2013
    Article
  18. Article
  19. Article
  20. MicroRNAs in common human diseases.Genomics, proteomics & bioinformatics · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

S KauppinenDepartment of Functional Genomics, Exiqon, Bygstubben 9, 2950 Vedbaek, Denmark.
B Vester
J Wengel
University of Southern Denmark · DKHolbæk Sygehus · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Locked nucleic acid (LNA) is a nucleic acid analog containing one or more LNA nucleotide monomers with a bicyclic furanose unit locked in an RNA-mimicking sugar conformation. This conformational restriction is translated into unprecedented hybridization affinity towards complementary single-stranded RNA molecules. That makes fully modified LNAs, LNA/DNA mixmers, or LNA/RNA mixmers uniquely suited for mimicking RNA structures and for RNA targeting in vitro or in vivo. The focus of this chapter is on LNA antisense, LNA-modified DNAzymes (LNAzymes), LNA-modified small interfering (si)RNA (siLNA), LNA-enhanced expression profiling by real-time RT-PCR and detection and analysis of microRNAs by LNA-modified probes.

Indexed as

AnimalsHumansNucleic AcidsRNARNA, AntisenseRNA, ComplementaryRNA, Small InterferingNucleic AcidsRNARNA, AntisenseRNA, ComplementaryRNA, Small Interfering

Identifiers

PMID16594628
PMCPMC7120141
OpenAlexW94815550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.